Optimized Ratiometric Voltage-Sensitive Dyes for Cardiac Research, Safety Pharmacology
用于心脏研究、安全药理学的优化比例电压敏感染料
基本信息
- 批准号:10699121
- 负责人:
- 金额:$ 95.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-08 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Action PotentialsArrhythmiaBasic ScienceBiological AssayBusinessesCardiacCardiac Electrophysiologic TechniquesCardiac MyocytesCardiotoxicityCatalogsCell LineCell membraneCellsChemicalsClinicalCommunitiesConnecticutDevelopmentDrug ScreeningDrug toxicityDyesElectrodesElectrophysiology (science)FluorescenceFluorescent DyesFutureGenerationsGenetic Predisposition to DiseaseGoalsGrowthHeartHeart ResearchHeart failureHumanImageIndividualLegal patentLicensingLightLinkMapsMarketingMeasuresMethodsMorphologic artifactsMotionNeurosciencesNoiseOpticsOrganPatientsPenetrationPerformancePharmaceutical PreparationsPharmacologyPhasePhysiologyPreparationPropertyProteinsReagentRecordsResearchResearch PersonnelResolutionSafetyScientistSignal TransductionSmall Business Innovation Research GrantSourceSpeedStainsTechnologyTestingThickTimeTissuesToxic effectToxicologyUniversitiesWorkcalcium indicatorchromophoreclinical imagingcommercializationdesigndrug actiondrug discoveryexperimental studyheart cellhigh resolution imaginghigh throughput screeninghuman stem cellsimprovedin vivoinduced pluripotent stem cell derived cardiomyocytesinsightinventionlight intensitynovelnovel therapeuticsoptogeneticspersonalized diagnosticspersonalized medicineratiometricrational designresearch and developmentscreeningspatiotemporaltissue/cell culturetoolvoltagevoltage sensitive dyewater solubility
项目摘要
Project Summary/Abstract Potentiometric Probes
The overall goal of this Phase II SBIR project is to commercialize tools, invented by the
founders of Potentiometric Probe, LLC, for high-fidelity optical recording of electrical activity in
cardiac cells, tissues, and whole hearts. Potentiometric Probes develops organic
voltage-sensitive dyes (VSDs) that convert the changes in voltage across cell membranes to
visible changes in fluorescence. Instead of individual electrodes, this technology enables the
use of sensitive high-speed cameras, where each pixel can be considered an electrode, for
massively parallel high throughput screening, or for high-resolution spatiotemporal maps of
electrical signal propagation. Importantly, our VSDs are unique in enabling dual-wavelength
ratiometric recording of electrical activity; this is particularly important for cardiac studies
because it eliminates contraction-induced motion artifacts, permitting high-fidelity records of the
action potential waveform. Human stem cell-derived cardiomyocytes (hiPSC-CMs) and tissues
derived from them are increasingly being used for research and development purposes,
including screening new drugs for cardiotoxicity, and in the future may be used for “personalized
medicine” and the analysis of patient-derived cells. We believe high throughput recording of
accurate action potential waveforms from hiPSC-CMs and tissues will be a major market for the
proposed technology. Ultimately, the technology may also be applied clinically for
high-resolution imaging of action potential propagation in the heart. In this proposal,
Potentiometric Probes will synthesize a set of stable, non-toxic ratiometric VSDs with a broad
selection of spectral windows, allowing accurate recordings even from beating hearts. The
performance of these VSDs will also be fully characterized and validated for their compatibility
with sensitive cell lines for both long-term and high-throughput recordings.
项目摘要/抽象电位测头
这个第二阶段SBIR项目的总体目标是将由
用于高保真光学记录电活动的电位计探头LLC的创始人
心肌细胞、组织和整个心脏。电位法探头显影有机
电压敏感染料(VSD),将细胞膜上的电压变化转换为
可见的荧光变化。这项技术不是单独的电极,而是使
使用灵敏的高速摄像机,其中每个像素都可以被视为电极,用于
大规模并行高通量筛选,或用于高分辨率时空地图
电信号传播。重要的是,我们的VSD在支持双波长方面独一无二
电活动的比率记录;这对心脏研究特别重要
因为它消除了收缩引起的运动伪像,允许高保真地记录
动作电位波形。人干细胞来源的心肌细胞和组织
从它们衍生出来的越来越多地被用于研究和开发目的,
包括筛选心脏毒性的新药,并在未来可能被用于“个性化”
医学“和病人来源细胞的分析。我们相信高通量记录
来自HiPSC-CMS和组织的准确动作电位波形将是
建议的技术。最终,这项技术也可能应用于临床
心脏动作电位传播的高分辨率成像。在这份提案中,
电位法探针将合成一套稳定、无毒的比例式VSD,具有广泛的
选择光谱窗口,即使是跳动的心脏也能进行准确的记录。这个
还将对这些VSD的性能进行全面表征,并验证其兼容性
具有敏感的细胞系,可用于长期和高通量记录。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Corey Acker其他文献
Corey Acker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Corey Acker', 18)}}的其他基金
Improved Ratiometric Voltage-Sensitive Dyes for In-Vitro and In-Vivo Imaging of Brain Electrical Signaling
改进的比例电压敏感染料用于脑电信号的体外和体内成像
- 批准号:
10018113 - 财政年份:2019
- 资助金额:
$ 95.85万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:














{{item.name}}会员




